Search

The aim of the present study was to develop low‐cost techniques for culturing seahorses in extensive shrimp ponds to foster a legal and more sustainable production chain to meet market demand for traditional Chinese medicine. In the present article, the results of two‐year experiments of seahorse culture in cages and extensive shrimp ponds are reported. We found that juveniles of the lined seahorse survived in cages and ponds very well, and the juvenile survival generally was >70% during the experimental periods. The survival and growth of the juveniles were similar to or even better than that reported in indoor tank culture. Additionally, the lined seahorse survived well (>60%) at temperatures up to 34.6°C which is the highest recorded temperature for the species in the field. For large ponds of >5 ha, cage culture may be a better way. For small ponds of <0.3 ha, culturing the seahorse in a pond is recommended. A 1000 m2 pond could support around 7000 of the juveniles of the lined seahorse. In conclusion, culturing the lined seahorse in an extensive shrimp pond is technically feasible. [ABSTRACT FROM AUTHOR]

A two‐factorial experiment (temperature with three levels: 23°C, 25.5°C and 28°C; diet with four kinds: live Artemia sp., copepods, live Artemia sp. + copepods and frozen Neomysis awatschensis [FNA]) was carried out to evaluate the effects of different temperatures and diets on biochemistry in the juvenile lined seahorse (Hippocampus erectus) for thirty days. The juveniles (n = 1260, body height: 5.1 ± 0.48 cm, initial wet weight: 0.42 ± 0.14 g) were distributed in 36 experimental aquaria (35 individuals each). Each treatment had 3 replicates. On day 30, the seahorses were vacuum freeze‐dried at −56°C before chemical analysis. Amino acids, fatty acids, Se, Zn, nucleosides, and nucleotides were measured in the present study. The results show that temperature, diet, and their interaction significantly affected all components. The content of amino acids and fatty acids in the juveniles fed FNA at 23°C was the highest. The content of Zn in the juveniles fed FNA at 23°C, and the content of Se fed Artemia sp. + copepod at 25.5°C were the highest, respectively. The content of uracil, adenine, and thymidine in the juveniles at 23°C was significantly lower than those treatments at 25.5°C and 28°C. The levels of uracil, guanine, cytosine, uridine, and guanosine at 28°C were significantly higher than those at 23°C or 25.5°C when fed Artemia sp. + copepod. The juveniles fed Artemia sp. + copepod and Artemia sp. at 28°C has the highest comprehensive scores of nucleoside and nucleotide. In conclusion, FNA is the best feed to improve the content of amino acids, fatty acids, and Zn at 23°C. [ABSTRACT FROM AUTHOR]

With the global prevalence of COVID‐19 and the constant emergence of viral variants, boosters for COVID‐19 vaccines to enhance antibody titers in human bodies will become an inevitable trend. However, there is a lack of data on antibody levels and the protective effects of booster injections. This study monitored and analyzed the antibody potency and the antibody responses induced by the booster injection in the subjects who received three vaccine doses. The study was conducted in a multicenter collaboration and recruited 360 healthy adults aged 20–74. Participants received the first, second, and booster doses of inactivated Sinopharm/BBIBP COVID‐19 vaccine at 0, 1, and 7 months. Vaccine‐induced virus‐specific antibody levels (SARS‐COV‐2‐IgA/IgM/IgG) were monitored at multiple time points, surrogate virus neutralization test (sVNT), and the spatial distribution and proportion of immune cells and markers were analyzed using the CyTOF method before vaccination and a month after the second dose. The titers of SARS‐CoV‐2‐IgA/IgM/IgG and neutralizing antibodies increased to a high level in the first month after receiving the second dose of vaccine and declined slowly after that. The antibody levels of SARS‐CoV‐2‐IgG and sVNT were significantly increased at 0.5 months after the induction of the booster (p < 0.05). Despite a downward trend, the antibody levels were still high in the following 6 months. The B cell concentration (in humoral sample) a month after the second injection was significantly reduced compared to that before the vaccine injection (p < 0.05). The proportion of the C01 cell cluster was significantly decreased compared with that before vaccine injection (p < 0.05). Individual cell surface markers showed distinctions in spatial distribution but were not significantly different. This study has shown that serum antibody titer levels will decrease with time by monitoring and analyzing the antibody efficacy and the antibody reaction caused by the booster injection of healthy people who received the whole vaccination (completed three injections). Still, the significant peak of the antibody titer levels after booster highlights the recall immune response. It can maintain a high concentration of antibody levels for a long time, which signifies that the protection ability has been enhanced following the injection of booster immunization. Additionally, CyTOF data shows the active production of antibodies and the change in the immunity environment. [ABSTRACT FROM AUTHOR]

Background: The inactivated Sinopharm/BBIBP COVID‐19 vaccine has been widely used in the world and has joined the COVAX vaccine supply program for developing countries. It is also well adapted for usage in low‐ and middle‐income nations due to their low storage requirements. Objective: This study aims to report on the kinetics, durability, and neutralizing ability of the induced immunity of the BBIBP vaccine, and the intensified antibody response elicited by the booster. Methods: A total of 353 healthy adult participants, aged 20–74 years, were recruited in this multicenter study. A standard dose of the BBIBP vaccine was administered (Month 0), followed by a second standard dose (Month 1), and a booster dose (after Month 7). Vaccine‐induced virus‐specific antibody levels (SARS‐CoV‐2‐IgA/IgM/IgG), conventional virus neutralization test (cVNT), pseudovirus neutralization test (pVNT), and surrogate virus neutralization test (sVNT) were monitored over multiple time points. Results: Neutralizing titers induced by the two doses of inactivated vaccine for COVID‐19 peaked at Month 2 and declined to 33.89% at Month 6. Following the booster dose, elevated levels of antibodies were induced for IgA, IgG, and neutralizing antibodies, with neutralizing titer reaching 13.2 times that of before the booster. Conclusion: By monitoring the antibody titer levels postvaccination, this study has shown that serum antibody levels will decrease over time, but a notable spike in antibody levels postbooster highlights the anamnestic immune response. This signifies that the protection capability has increased following the injection of booster immunization. [ABSTRACT FROM AUTHOR]

Zebrafish skeletal muscles are broadly divided into slow‐twitch and fast‐twitch muscle fibers. The slow fibers, which express a slow fiber‐specific myosin heavy chain 1 (Smyhc1), are the first group of muscle fibers formed during myogenesis. To uncover Smyhc1 function in muscle growth, we generated three mutant alleles with reading frame shift mutations in the zebrafish smyhc1 gene using CRISPR. The mutants showed shortened sarcomeres with no thick filaments and M‐lines in slow fibers of the mutant embryos. However, the formation of slow muscle precursors and expression of other slow muscle genes were not affected and fast muscles appeared normal. The smyhc1 mutant embryos and larvae showed reduced locomotion and food intake. The mutant larvae exhibited increased lethality of incomplete penetrance. Approximately 2/5 of the homozygous mutants were viable and grew into reproductive adults. These adult mutants displayed a typical pattern of slow and fast muscle fiber distribution, and regained normal slow muscle formation. Together, our studies indicate that Smyhc1 is essential for myogenesis in embryonic slow muscles, and loss of Smyhc1 results in defective sarcomere assembly, reduces larval motility and fish survival, but has no visible impact on muscle growth in juvenile and adult zebrafish that escape the larval lethality. [ABSTRACT FROM AUTHOR]